Conformis (NASDAQ:CFMS) versus Cadre (NYSE:CDRE) Head-To-Head Review

Conformis (NASDAQ:CFMS) and Cadre (NYSE:CDRE) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, valuation, analyst recommendations, institutional ownership, risk, profitability and earnings.

Institutional & Insider Ownership

39.2% of Conformis shares are owned by institutional investors. 3.0% of Conformis shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Profitability

This table compares Conformis and Cadre’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Conformis 6.86% 8.19% 5.11%
Cadre N/A N/A N/A

Earnings & Valuation

This table compares Conformis and Cadre’s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Conformis $68.76 million 1.81 -$24.29 million ($0.03) -22.26
Cadre N/A N/A N/A N/A N/A

Cadre has lower revenue, but higher earnings than Conformis.

Analyst Ratings

This is a summary of current ratings for Conformis and Cadre, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Conformis 0 0 1 0 3.00
Cadre 0 1 5 0 2.83

Conformis currently has a consensus price target of $2.00, indicating a potential upside of 199.40%. Cadre has a consensus price target of $23.60, indicating a potential upside of 9.36%. Given Conformis’ stronger consensus rating and higher possible upside, equities analysts plainly believe Conformis is more favorable than Cadre.

Summary

Conformis beats Cadre on 8 of the 9 factors compared between the two stocks.

About Conformis

ConforMIS, Inc. is a medical technology company, which engages in the development, manufacture, and sale of joint replacement implants. It operates through the following geographical segments: United States; Germany; and Rest of the World. The firm’s products include iUni, iDuo, iTotal CR, and iTotal. The company was founded by Philipp Lang in 2004 and is headquartered in Billerica, MA.

About Cadre

Cadre Holdings Inc. is a manufacturer and distributer of safety and survivability equipment for first responders. The Company’s core products include body armor, explosive ordnance disposal equipment and duty gear. Its primarily brands include Safariland(R) and Med-Eng(R). Cadre Holdings Inc. is headquartered in Jacksonville, Florida.

Receive News & Ratings for Conformis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Conformis and related companies with MarketBeat.com's FREE daily email newsletter.